{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:55:44Z","timestamp":1765886144428,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Offering a financial incentive (\u2018Money for Medication\u2019) is effective in improving adherence to treatment with depot antipsychotic medications. We investigated the cost-effectiveness in terms of medical costs and judicial expenses of using financial incentives to improve adherence. The effects of financial incentives on depot medication adherence were evaluated in a randomised controlled trial. Patients in the intervention group received \u20ac30 a month over 12\u00a0months if antipsychotic depot medication was accepted. The control group received mental health care as usual. For 133 patients outcomes were calculated based on self-reported service use and delinquent behaviour and expressed as standard unit costs to value resource use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The financial incentive resulted in higher average costs related to mental health care (\u20ac449.6 versus \u20ac355.7). and lower medical costs related to other healthcare services (\u20ac52.0 versus \u20ac78.4). Relevant differences in social costs related to delinquent behaviour were not found. Although wide confidence intervals indicate uncertainty, incremental cost-effectiveness ratio\u2019s (ICER) indicate that it costs \u20ac2080 for achieving a 20% increase in adherence or \u20ac3332 for achieving over 80% adherence. In sum, offering money as financial incentive for increasing compliance did not lead to an overall cost reduction as compared to care as usual.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> NTR2350, 01 June 2010<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-018-3747-1","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T13:08:14Z","timestamp":1536584894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Medical and social costs after using financial incentives to improve medication adherence: results of a 1\u00a0year randomised controlled trial"],"prefix":"10.1186","volume":"11","clinical-trial-number":[{"clinical-trial-number":"ntr2350","registry":"10.18810\/dutch-trial-register"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4287-7647","authenticated-orcid":false,"given":"Ernst L.","family":"Noordraven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 I.","family":"Wierdsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Blanken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony F. T.","family":"Bloemendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis L.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"3747_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2010.11.020","volume":"127","author":"C Leucht","year":"2011","unstructured":"Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S. Oral versus depot antipsychotic drugs for schizophrenia\u2014a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res. 2011;127:83\u201392.","journal-title":"Schizophr Res"},{"key":"3747_CR2","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1192\/bjp.195.52.s37","volume":"52","author":"TRE Barnes","year":"2009","unstructured":"Barnes TRE, Shingleton-Smith A, Paton C. Antipsychotic long-acting injections: prescribing practice in the UK. Br J Psychiatry Suppl. 2009;52:S37\u201342.","journal-title":"Br J Psychiatry Suppl"},{"key":"3747_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5847","author":"S Priebe","year":"2013","unstructured":"Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, David AS, O\u2019Connell N, Forrest A, Burns T. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ. 2013. https:\/\/doi.org\/10.1136\/bmj.f5847.","journal-title":"BMJ"},{"key":"3747_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S2215-0366(17)30045-7","volume":"4","author":"EL Noordraven","year":"2017","unstructured":"Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Staring ABP, Mulder CL. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial. Lancet Psychiatry. 2017;4:199\u2013207.","journal-title":"Lancet Psychiatry"},{"key":"3747_CR5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s40273-013-0108-8","volume":"31","author":"EJM Oberj\u00e9","year":"2013","unstructured":"Oberj\u00e9 EJM, De Kinderen RJA, Evers SMAA, Van Woerkum CMJ, De Bruin M. Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations. Pharmacoeconomics. 2013;31:1155\u201368.","journal-title":"Pharmacoeconomics"},{"key":"3747_CR6","first-page":"1","volume":"10","author":"C Henderson","year":"2015","unstructured":"Henderson C, Knapp M, Yeeles K, Bremner S, Eldridge S, David AS, O\u2019Connell N, Burns T, Priebe S. Cost-effectiveness of financial incentives to promote adherence to depot antipsychotic medication: economic evaluation of a cluster-randomised controlled trial. PLoS ONE. 2015;10:1\u201318.","journal-title":"PLoS ONE"},{"key":"3747_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12888-014-0343-3","volume":"14","author":"EL Noordraven","year":"2014","unstructured":"Noordraven EL, Audier CH, Staring A, Wierdsma AI, Blanken P, van der Hoorn B, Roijen L, Mulder CL. Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders. BMC Psychiatry. 2014;14:343.","journal-title":"BMC Psychiatry"},{"key":"3747_CR8","first-page":"5","volume":"7","author":"L Hakkaart-van Roijen","year":"2002","unstructured":"Hakkaart-van Roijen L. Trimbos\/iMTA questionnaire for costs associated with psychiatric illness (TiC-P). iMTA. 2002;7:5\u201345.","journal-title":"iMTA"},{"key":"3747_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12888-016-0758-0","volume":"16","author":"JM Somers","year":"2016","unstructured":"Somers JM, Moniruzzaman A, Currie L, Rezansoff SN, Russolillo A, Parpouchi M. Accuracy of reported service use in a cohort of people who are chronically homeless and seriously mentally ill. BMC Psychiatry. 2016;16:41.","journal-title":"BMC Psychiatry"},{"key":"3747_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jval.2015.07.006","volume":"18","author":"R Timman","year":"2015","unstructured":"Timman R, Bouwmans C, Busschbach JJV, Hakkaart-Van Roijen L. Development of the treatment inventory of costs in psychiatric patients: TIC-P Mini and Midi. Value Heal. 2015;18:994\u20139.","journal-title":"Value Heal"},{"key":"3747_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/0049124102030004002","volume":"30","author":"AR Piquero","year":"2002","unstructured":"Piquero AR, Macintosh R, Hickman M. The validity of a self-reported delinquency scale. Soc Methods Res. 2002;30:492\u2013529.","journal-title":"Soc Methods Res"},{"key":"3747_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugalcdep.2011.05.021","volume":"119","author":"V Hendriks","year":"2011","unstructured":"Hendriks V, van der Schee E, Blanken P. Treatment of adolescents with a cannabis use disorder: main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug Alcohol Depend. 2011;119:64\u201371.","journal-title":"Drug Alcohol Depend"},{"key":"3747_CR13","volume-title":"Explaining delinquency and drug use","author":"DS Elliot","year":"1985","unstructured":"Elliot DS, Huizinga D, Ageton SS. Explaining delinquency and drug use. Beverly Hills: Sage Publications; 1985."},{"key":"3747_CR14","volume-title":"Wetenschappelijk Onderzoek en Documentatie Centrum Documentatie Vragenlijst Internationaal Onderzoek Selfreport Delictgedrag (Questionnaire International Study Self-Report Deliquency)","author":"WODC","year":"1991","unstructured":"WODC. Wetenschappelijk Onderzoek en Documentatie Centrum Documentatie Vragenlijst Internationaal Onderzoek Selfreport Delictgedrag (Questionnaire International Study Self-Report Deliquency). Den Haag: Ministry of Justice; 1991."},{"key":"3747_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.drugalcdep.2016.03.004","volume":"162","author":"M Goorden","year":"2016","unstructured":"Goorden M, van der Schee E, Hendriks VM, Hakkaart-van Roijen L. Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: data from a randomized controlled trial. Drug Alcohol Depend. 2016;162:154\u201361.","journal-title":"Drug Alcohol Depend"},{"key":"3747_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/intqhc\/mzr010","volume":"23","author":"D Gregori","year":"2011","unstructured":"Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Heal care J Int Soc Qual Heal Care. 2011;23:331\u201341.","journal-title":"Int J Qual Heal care J Int Soc Qual Heal Care"},{"key":"3747_CR17","first-page":"1","volume":"70","author":"DI Velligan","year":"2009","unstructured":"Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70:1\u201346.","journal-title":"J Clin Psychiatry"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-018-3747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:55:14Z","timestamp":1628614514000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-018-3747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3747"],"URL":"https:\/\/doi.org\/10.1186\/s13104-018-3747-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"15 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"655"}}